Two patients treated with NIVO3 + IPI1 had a history of chronic inflammatory disease, one with cutaneous psoriasis that worsened along with the onset of arthritis, successfully treated with methotrexate and oral prednisone; the other patient had rheumatoid arthritis treated with oral steroids that remained stable. This evidence concerns the gene TEX10 and rheumatoid arthritis.